Implementation of low-cost drugs confused directory- Pharmaceutical marketing policy perspective.docVIP

  • 3
  • 0
  • 约3.61千字
  • 约 3页
  • 2017-05-03 发布于浙江
  • 举报

Implementation of low-cost drugs confused directory- Pharmaceutical marketing policy perspective.doc

Implementation of low-cost drugs confused directory- Pharmaceutical marketing policy perspective

 PAGE \* MERGEFORMAT 3 Implementation of low-cost drugs confused directory: Pharmaceutical marketing policy perspective National drug catalog introduction of low-priced starting point is to protect low-priced products, especially generic drugs homogeneity strong product avoid hanging purchases due to intense competition, price margins drastically reduced until less than the operating costs of enterprises and channel marketing, companies have no incentive Even upside down management, case goods sadly disappearing from the market. But from a market point of view of the implementation of low-cost drugs, but inevitably confused directory. First, the average daily cost of cheap medicine directory medicine three yuan, Chinese 5 yuan, 21 yuan, compared with weeks of treatment costs and $ 35 monthly cost of treatment, compared with 90 and 150 respectively. Already close to or even higher than many new drugs, new formulations retail price, taking into account the price factor linked network, there will be some of the traditional price of generic drugs over a large area of #8203;#8203;high drug non-normal conditions after the actual implementation. With better outcomes, better treatment cost of survival of the fittest is the natural law of the market competition. Scale production of generic drugs should be significantly lower than the cost of the drug product, the marketing of generic drugs is much lower than the operating costs of new drug products. Ensure that the market is more in line with the objective of fair competition law is extremely important. Second, when the countries to develop low-cost directory does not fully take into account differences in the cost of production formulations and doses, the average daily use of a low-cost drugs and 10 injections, 1 and 18 tablets cost of production is completely different. Version GMP transformation after injection products cost much higher than oral products, the same will be the actual implementation of the or

文档评论(0)

1亿VIP精品文档

相关文档